SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as SB-715992, work in different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well SB-715992 works in treating patients with
metastatic or recurrent malignant melanoma.